Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Press Releases
Lucid Diagnostics, PAVmed Inc.  
February 25, 2025

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM),

avatar profile Olean Times Herald

Olean Times Herald


Local & Social